CAS: 63527-53-7 - 3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Fórmula:C16H17N5O7S2
InChI:InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9+/t10-,14-/m1/s1
Clave InChI:InChIKey=GPRBEKHLDVQUJE-VINNURBNSA-N
SMILES:O=C(O)C1=C(COC(=O)C)CSC2N1C(=O)C2NC(=O)C(=NOC)C=3N=C(SC3)N
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Cefotaxime EP Impurity D Sodium Salt ((E)-Cefotaxime Sodium Salt) REF: 4Z-C-106006CAS: | - - - | A consultar | Mar 07 Ene 25 | |
(E)-Cefotaxime REF: TR-C242960CAS: 63527-53-7 | - - - | 10.963,00 € | Mar 18 Feb 25 | |
(E)-Cefotaxime REF: 3D-NCA52753CAS: 63527-53-7 | Min. 95% | A consultar | Mar 18 Feb 25 |
Cefotaxime EP Impurity D Sodium Salt ((E)-Cefotaxime Sodium Salt)
Ref: 4Z-C-106006
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
(E)-Cefotaxime
Producto controladoRef: TR-C242960
25mg | 10.963,00 € |
(E)-Cefotaxime
Ref: 3D-NCA52753
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |